Yao Lu

机构：Wujiang District People's Hospital, First Affiliated Hospital of Zhengzhou University, The Fifth People’s Hospital of Suzhou · ORCID：0000-0001-8498-7989

发表论文 39 篇 · 总被引 629 次 · h-index 11

代表论文

• The consistency of neuropathological diagnoses in patients undergoing surgery for suspected recurrence of glioblastoma (2018 · Journal of Neuro-Oncology · 被引 43)
• Predictive Significance Of Preoperative Systemic Immune-Inflammation Index Determination In Postoperative Liver Metastasis Of Colorectal Cancer (2019 · OncoTargets and Therapy · 被引 41)
• Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Carcinoma by Inhibiting IL-6 Signaling Pathway (2021 · Frontiers in Oncology · 被引 27)
• Clinical benefits of PD-1 inhibitors in specific subgroups of patients with advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis of phase 3 randomized clinical trials (2023 · Frontiers in Immunology · 被引 19)
• The efficacy and safety of antibodies targeting PD-1 for treatment in advanced esophageal cancer: A systematic review and meta-analysis (2021 · Translational Oncology · 被引 15)
• Predictive markers for severe hypocalcemia in dialysis patients with secondary hyperparathyroidism after near-total parathyroidectomy (2021 · Annals of Palliative Medicine · 被引 14)